The patient's perspective on stereotactic body radiation therapy (SBRT) vs. surgery for treatment of early stage non-small cell lung cancer (NSCLC)

Lung Cancer

Volumn 90, Issue 2, 2015, Pages 230-233

  Shaverdian, Narek ^a   Wang, Pin Chieh ^a   Steinberg, Michael ^a   Lee, Percy ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Lung cancer; Non small cell lung cancer; Patient reported outcomes; SBRT; Surgery

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CAREGIVER BURDEN; CONTROLLED STUDY; HUMAN; INTERMETHOD COMPARISON; LOBECTOMY; LUNG SURGERY; MAJOR CLINICAL STUDY; MINIMALLY INVASIVE SURGERY; MULTIMODALITY CANCER THERAPY; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; STEREOTACTIC BODY RADIATION THERAPY; THERAPY EFFECT; VIDEO ASSISTED THORACOSCOPIC SURGERY; CARCINOMA, NON-SMALL-CELL LUNG; LUNG NEOPLASMS; LUNG RESECTION; PATHOLOGY; PROCEDURES; RADIOSURGERY; TREATMENT OUTCOME;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PNEUMONECTOMY; RADIOSURGERY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84940919786     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2015.07.009     Document Type: Article

References (15)

1. SEER Cancer Statistics Review 1975-2011, (updated December 17, 2014). N. Howlader, A.M. Noone, M. Krapcho (Eds.).
2. The national lung screening trial research team Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med. 2011, 365:395-409.
3. Smythe W.R. Treatment of stage I non-small cell lung carcinoma. Chest 2003, 123:181-187.
4. Timmerman R., Paulus R., Galvin J., et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010, 303:1070-1107.
5. Shirvani S.M., Jiang J., Chang J.Y., et al. Comparative effectiveness of five treatment strategies for early-stage non-small cell lung cancer in the elderly. Int. J. Radiat. Oncol. Biol. Phys. 2012, 84:1060-1070.
6. Bott M.J., Crabtree T. Treatment of stage I lung cancer in high-risk and inoperable patients: SBRT vs. RFA vs. sublobar resection. Ann. Cardiothorac. Surg. 2014, 3:167-169.
7. Lagerwaard F.J., Verstegen N.E., Haasbeek C.J., et al. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 2012, 83:348-353.
8. Crabtree T.D., Denlinger C.E., Meyers B.F., et al. Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 2010, 140:377-386.
9. Sun V., Kim J.Y., Williams A.C., et al. Quality of life and symptoms following stereotactic body radiation therapy in early-stage lung cancer patients. J. Community Support Oncol. 2014, 12:407-414.
10. Lagerwaard F.J., Aaronson N.K., Gundy C.M., et al. Patient-reported quality of life after stereotactic ablative radiotherapy for early-stage lung cancer. J. Thorac. Oncol. 2012, 7:1148-1154.
11. Van der Voort van Zyp N.C., Prevost J.B., Van der Holt B., et al. Quality of life after stereotactic radiotherapy for stage I non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 2010, 77:31-37.
12. Videtic G.M., Reddy C.A., Sorenson L. A prospective study of quality of life including fatigue and pulmonary function after stereotactic body radiatiotherpay for medically inoperable ear-stage lung cancer. Support Care Cancer. 2013, 21:211-218.
13. Koshy M., Malik R., Spiotto M., et al. Disparities in treatment of patients with inoperable stage I non-small cell lung cancer: a population-based analysis. J. Thorac. Oncol. 2015, 10:264-271.
14. Teckie S., McCloskey S.A., Steinberg M.L. Value: a framework for radiation oncology. J. Clin. Oncol. 2014, 32:2864-2870.
15. Porter M.E. What is value in healthcare?. N. Engl. J. Med. 2010, 363:2477-2481.